Class IIOngoingD-0463-2022
Drug recall · February 9, 2022
Medroxyprogesterone Acetate Injection recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Medroxyprogesterone Acetate Injection, IM, 150 mg/mL, packaged in 1 ml Single Dose Vial, RX Only, Ideal Pharmacy, 2333 Morris Ave, Union, NJ 07083
- Lots / codes
All lots within expiry
- Quantity
- 57,994 vials
- Company
- Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy, Union, NJ
- Distribution
- nationwide in the USA
- Initiated
- December 21, 2021 · Voluntary: Firm initiated
- Classified
- January 31, 2022
- Reported
- February 9, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Medroxyprogesterone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.